Zurcher Kantonalbank »

Adagio Therapeutics shares owned by Zurcher Kantonalbank

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by Zurcher Kantonalbank from 13F filings

Historical chart of Zurcher Kantonalbank investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by Zurcher Kantonalbank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by Zurcher Kantonalbank

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.7k 5.2k 1.30

More positions owned by Zurcher Kantonalbank

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ubs Group SHS (UBS)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alcon Ord Shs (ALC)
Eli Lilly & Co. (LLY)
Amrize SHS (AMRZ)
JPMorgan Chase & Co. (JPM)
Wal-Mart Stores (WMT)

View all positions for Zurcher Kantonalbank

Top funds holding Adagio Therapeutics

Henderson Group
Perceptive Advisors
BVF
Maverick Capital
Driehaus Capital Management
Vanguard Group
Vanguard Capital Management
M28 Capital Management
Saturn V Capital Management
Soleus Capital Management
Eventide Asset Management
State Street Corporation
BlackRock
Siren
ADAR1 Capital Management

View all funds holding Adagio Therapeutics